These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 4727362)

  • 41. Synthesis of new 3-(pyridin-6-yl)pyrazolo[1,5-a]pyrimidines.
    Ibrahim NS; Mohamed MH; Elnagdi MH
    Arch Pharm (Weinheim); 1987 Jun; 320(6):487-91. PubMed ID: 3662773
    [No Abstract]   [Full Text] [Related]  

  • 42. Facile synthesis and in-vitro antitumor activity of some pyrazolo[3,4-b]pyridines and pyrazolo[1,5-a]pyrimidines linked to a thiazolo[3,2-a]benzimidazole moiety.
    Abdel-Aziz HA; Saleh TS; El-Zahabi HS
    Arch Pharm (Weinheim); 2010 Jan; 343(1):24-30. PubMed ID: 19921685
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis and antischistosomal activity of certain pyrazolo[1,5-a]pyrimidines.
    Senga K; Novinson T; Wilson HR; Robins RK
    J Med Chem; 1981 May; 24(5):610-3. PubMed ID: 7241518
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 3-Hydroxy-1-nitrophenyl-1(H-pyrazolo(3,4-b)pyridines as selective inhibitors of rat liver xanthine oxidase.
    Parmar SS; Pandey BR; Dwivedi C; Ali B
    J Med Chem; 1974 Sep; 17(9):1031-3. PubMed ID: 4416932
    [No Abstract]   [Full Text] [Related]  

  • 45. [Synthesis of pyrazole derivatives and pyrazolo[4,3-d]pyrimidines. I].
    Baraldi PG; Vicentini CB; Simoni D; Guarneri M
    Farmaco Sci; 1983 Jun; 38(6):370-5. PubMed ID: 6603373
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 6,7-Dihydro-5H-cyclopenta[d]pyrazolo[1,5-a]pyrimidines and their derivatives as novel corticotropin-releasing factor 1 receptor antagonists.
    Saito T; Obitsu T; Kondo T; Matsui T; Nagao Y; Kusumi K; Matsumura N; Ueno S; Kishi A; Katsumata S; Kagamiishi Y; Nakai H; Toda M
    Bioorg Med Chem; 2011 Sep; 19(18):5432-45. PubMed ID: 21865047
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pyrazolo[3,4-d]pyrimidines endowed with antiproliferative activity on ductal infiltrating carcinoma cells.
    Carraro F; Pucci A; Naldini A; Schenone S; Bruno O; Ranise A; Bondavalli F; Brullo C; Fossa P; Menozzi G; Mosti L; Manetti F; Botta M
    J Med Chem; 2004 Mar; 47(7):1595-8. PubMed ID: 15027847
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel 3-alkoxy-1H-pyrazolo[3,4-d]pyrimidines as EGFR and erbB2 receptor tyrosine kinase inhibitors.
    Ducray R; Ballard P; Barlaam BC; Hickinson MD; Kettle JG; Ogilvie DJ; Trigwell CB
    Bioorg Med Chem Lett; 2008 Feb; 18(3):959-62. PubMed ID: 18182285
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tyrosine kinase inhibition effects of novel Pyrazolo[1,5-a]pyrimidines and Pyrido[2,3-d]pyrimidines ligand: Synthesis, biological screening and molecular modeling studies.
    El Sayed MT; Hussein HAR; Elebiary NM; Hassan GS; Elmessery SM; Elsheakh AR; Nayel M; Abdel-Aziz HA
    Bioorg Chem; 2018 Aug; 78():312-323. PubMed ID: 29625271
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Discovery of pyrazolo[1,5-a]pyrimidine-based Pim inhibitors: a template-based approach.
    Dwyer MP; Keertikar K; Paruch K; Alvarez C; Labroli M; Poker C; Fischmann TO; Mayer-Ezell R; Bond R; Wang Y; Azevedo R; Guzi TJ
    Bioorg Med Chem Lett; 2013 Nov; 23(22):6178-82. PubMed ID: 24091081
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis of substituted pyrimidines, pyrazole[3,4-d]pyrimidines and imidazo[4,5-d]pyrimidines and evaluation of their antifungal activity.
    Ronsisvalle G; Pappalardo MS; Vittorio F; Pasquinucci L; Bousquet E; Oliveri S; Cammarata E
    Farmaco; 1989 Apr; 44(4):383-90. PubMed ID: 2775419
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis, EGFR Inhibition and Anti-cancer Activity of New 3,6-dimethyl-1-phenyl-4-(substituted-methoxy)pyrazolo[3,4-d] pyrimidine Derivatives.
    Bakr RB; Mehany ABM; Abdellatif KRA
    Anticancer Agents Med Chem; 2017; 17(10):1389-1400. PubMed ID: 28270084
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis and antiproliferative activity in vitro of new 2-, 3- or 4-substituted pyrido[2',3':3,4]pyrazolo[1, 5-a]pyrimidines.
    Poreba K; Wietrzyk J; Opolski A
    Acta Pol Pharm; 2006; 63(3):189-94. PubMed ID: 20085223
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel pyrazolo[3,4-d]pyrimidines: design, synthesis, anticancer activity, dual EGFR/ErbB2 receptor tyrosine kinases inhibitory activity, effects on cell cycle profile and caspase-3-mediated apoptosis.
    Maher M; Kassab AE; Zaher AF; Mahmoud Z
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):532-546. PubMed ID: 30688116
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Design and synthesis of novel pyrazolo[4,3-
    Wang BS; Huang X; Chen LZ; Liu MM; Shi JB
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1121-1130. PubMed ID: 31117832
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Action of some pyrazolopyrimidines on cell division. Study on the Allium test].
    Pautrat D; Deysson G; Truhaut R
    C R Acad Hebd Seances Acad Sci D; 1970 Jan; 270(1):120-2. PubMed ID: 4985453
    [No Abstract]   [Full Text] [Related]  

  • 57. Synthesis of pyrazolo[4',3':5,6]pyrano[2,3-d]pyrimidine derivatives for antiviral evaluation.
    Shamroukh AH; Zaki ME; Morsy EM; Abdel-Motti FM; Abdel-Megeid FM
    Arch Pharm (Weinheim); 2007 May; 340(5):236-43. PubMed ID: 17464958
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis, anticancer evaluation, and molecular docking studies of some novel 4,6-disubstituted pyrazolo[3,4-d]pyrimidines as cyclin-dependent kinase 2 (CDK2) inhibitors.
    Cherukupalli S; Chandrasekaran B; Kryštof V; Aleti RR; Sayyad N; Merugu SR; Kushwaha ND; Karpoormath R
    Bioorg Chem; 2018 Sep; 79():46-59. PubMed ID: 29753773
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Purine metabolism in the chick embryo; effects of uricogenesis and xanthine oxidase inhibition.
    Duggan DE; Pua KH; Elfenbein G
    Mol Pharmacol; 1968 Jan; 4(1):53-60. PubMed ID: 5640779
    [No Abstract]   [Full Text] [Related]  

  • 60. [Synthesis of substituted 6-phenylpyrazolo[3,4-d]pyrimidines with potential adenosin-A2A antagonistic activity].
    Briel D; Aurich R; Egerland U; Unverferth K
    Pharmazie; 2005 Oct; 60(10):732-5. PubMed ID: 16259118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.